![](/img/cover-not-exists.png)
Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany
Aileen R Neilson, Hilmar Burchardi, Chris Chinn, Johannes Clouth, Heinz Schneider, Derek AngusVolume:
18
Year:
2003
Language:
english
Pages:
11
DOI:
10.1016/j.jcrc.2003.10.005
File:
PDF, 116 KB
english, 2003